Civitavecchia, Italy

Maria Grazia Cima

This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Grazia Cima. Retrieved from https://idiyas.com/inventor/maria-grazia-cima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Grazia Cima: Innovator in Pharmaceutical Science

Introduction

Maria Grazia Cima is a notable inventor based in Civitavecchia, Italy. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative compounds for drug delivery. Her work is characterized by a commitment to advancing medical technology and improving patient outcomes.

Latest Patents

Maria Grazia Cima holds a patent for "Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds." This patent highlights her expertise in creating effective delivery systems for pharmaceuticals, showcasing her innovative approach to drug formulation.

Career Highlights

Cima is currently employed at Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she continues to push the boundaries of pharmaceutical research. Her work at Sigma-Tau has allowed her to collaborate with other talented professionals in the industry, further enhancing her contributions to the field.

Collaborations

Some of her notable coworkers include Maria Ornella Tinti and Mosè Santaniello. These collaborations have fostered a dynamic environment for innovation and have led to advancements in their shared research interests.

Conclusion

Maria Grazia Cima is a pioneering inventor whose work in pharmaceutical science is making a significant impact. Her dedication to innovation and collaboration continues to drive advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…